USE OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA (PPAR $f(a)) AGONIST FOR THE TREATMENT OF CARNITINE PALMITOYL TRANSFERASE-2 DEFICIENCIES

Details for Australian Patent Application No. 2003255893 (hide)

Owner INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)

Inventors BASTIN, Jean; DJOUADI, Fatima

Pub. Number AU-A-2003255893

PCT Number PCT/IB03/03527

PCT Pub. Number WO2004/022047

Priority 60/407,253 03.09.02 US

Filing date 26 August 2003

Wipo publication date 29 March 2004

International Classifications

A61K 031/19

Event Publications

6 November 2003 Complete Application Filed

  Priority application(s): 60/407,253 03.09.02 US

13 May 2004 Application Open to Public Inspection

  Published as AU-A-2003255893

19 May 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003255894-TRICHODERMA COMPOSITION

2003255892-Process for preparing a sterile high molecular weight hyaluronic acid formulation